Member Info for pomander

JM was on CNBC - forecasting that Facebook would halve in value in next 12 months - I did wonder if he had confused Facebook with RP ! RP very illiquid right now.

Relax Bignose- I thought you were coming off a good nights kip. Price action on such small volumes are indicative of any trend either way. I see them as positive when viewed in light of the post UK launch action. Its all about positive news/developmenets and this baby will blow !!!! Well, you know what I mean. Any luck pinning JM down - although would suspect he has a pretty full schedule?

Hope you waited for an even better day to buy today !

Ollie - �15m is a dop in the Ocean to what wil be needed here. Looks to me to cover short term funding issues- whilst I don't doubt Landsdowne fully bewhind Summ, they have little alternative but to support. The money will be spent fairly quickly- there are 10% more shares- not sure how you conclude little dilution. Beginning to have real doubts about Glyn's ability to deliver - he has history. Where's JM?

yes , but who are you ?

�If you owe your bank a hundred pounds, you have a problem. But if you owe a million, it has.� ― John Maynard Keynes Go argue with Mr Keynes

you don't have any assets - remember the banking crisis in 2008 ?

Probably an Asian Pharma Macau and HK can only be linked to China in some way. No commercial reason for seeking approval in these territories. Glad we got to the bottom of that !

bankrupcty serves no purpose - you have no assets so no recovery

Bignose - you are begfinning to sound more like me ! Purely wild speculation but what I think happened, is as follows; 1) following EMA approval protection, a large buyer wnet into the market with a very strong bid 2) approach to Maven made by buyers broker, so ready to move 3) maven sells into market in three tranchese to keep some sort of lid on SP 4) HK punters see the first day volume (650 m) and percentage rise - this must have been all over the BB's, local brokers - new Viagra blah, blah, blah etc 5) HK punters pile in days 2 & 3, churning the stock for a couple of days and creating the huge volumes (don't underestimate this - HK fouth largest exchange in the world) 5) buyer continues to buy until happy at which time he pulls his bid 6) traders start looking to bank profits and as they exit the price pulls back.

If you owe the bank a pound, you have the problem, if you owe the bank a million, the bank has the problem.

They are done and dusted in advance. Dissappointing but not surprising that been unable to find a licensee or partner to get C-Diff through P3 and to market. Drip feed funding of this nature is not the optimum approach.

Bignose - I broadly agree with your analysis, although I do not beleive RP had any involvement. I suspect the protection of the EMA approval was the trigger - going to look pertty dumb acquiring a stake in a company with no product. Maven's involvement is inetresting, were they made aware by a potential suitor of their intention or when they saw the liquidity being offered did they simply grasp that opprtunity to sell out their position, which they did almost immediately (days 12&3) so they clearly had their eye on the ball. RP updated its website in a timely fashion for the Maven disposal presuambly having been notified by Maven, but the HKSE was nnot updated for some months despite Maven being informed of the situation. Indeed JG also knew but choose to ignore as not RP's responsibility to notify the HKSE. When I contacted Mave about this they were so cagey it was untrue and the whole matter was referred to their compliance Dept. I don't understand the rationale for the delay in informing the HKSE, I thought it might be due to an off market deal at a higher price at the time but that is clearly not the case. I agree with your general point that the in light of recent share price action that the massive volumes that took off from the get go from the first bell market opening are very hard to fathom. The China situation is interesting me - suddenly thrown but never any detail and when does JG actually have to account for his previous comments about the status of lisences ?

Bignose - I don't really share that view. Did all the investors post the UK launch study developments back in 2014 ? They were not waiting for income, so what rattled their cages? Pharma investors typically invest years ahead of any income generation and indeed years ahead of even having an approved product. Typically there is just a crica 10% success rate from P1 to P3 and approval. Fortacin is ahead of this curve and the global market is siginificant and the comprtition limited. It would also seem to be a pretty good bet that FDA approval will follow and whilst we are frustrated, the timeframe for a new investor to come on board is not really an issue. So it seems to me that RP is either under the HK investor radar or the view on commercial prospects is very negative - indeed, it is pretty much currently priced to fail completely, if the listing valuation is correct. I don't know about large sums of money waiting at the doorstep, that was presumably one of the reasons behind moving Ple to HK, the 4th largest market in the world. It certainly arrived post the UK launch, but was this trading frenzy driven by one large buyer that others traded around until they acquired their poistion and the bid dried up. I continue to beleive from past events that a large stake post UK launch is the best fit., otherwise very difficult to make sense of the share price action / volumes over the last few months especially. Perhaps I am misunderstanding the dynamics of the HKSE.

fat finger syndrome- probably meant to sell 1000 or 10000 Price manipulation ! - too many conspiracy theories here, goes with the territory of a share price disaster - blame everyone but themselves for a poor investment decision.

Bignose- I think the past is almost entirely irrelavant to new investors. JM is as dissapointed and embarassed as anyone by the unforeseen delays, slow progress and poor expert advice. People are now calling for him to big it up - they can't have it both ways. I hope you get to speak to him.

Odd that tehre is no correlation between Phe SP and your endless flow of Google alerts on everythiung and anytrhging hydrogen. Suspect Shell could knock up a Moustrap in quick time or two without too much trouble. Best scientists and engineers on the planet.

If iii will not help and you cannot find another international broker which seems odd, conatct RP company secretary Stella Fang and see if she can suggest anything.

Do mainland chinese people matabolize prilociane in a different manner to chinese people in HK and Macau ? I don't recall seeing a question in the on line form asking if the intended user was of Chinese descent.

http://www.scmp.com/news/china/policies-politics/article/2114507/china-speed-approvals-new-drugs-and-will-accept-foreign http://www.scmp.com/news/hong-kong/health-environment/article/2124635/hong-kong-helps-speed-development-new-treatments Interesting Bakered - timeline would fit with JG's apparant about turn on China market.